throbber
Confirmation No. 2612
`
`Attorney Docket No. 2004__1016A
`
`Serial No. 10/500,354
`
`Filed June 30, 2004
`
`:
`
`:
`
`AQUEOUS LIQUID PREPARATIONS AND
`LIGHT-STABILIZED AQUEOUS LIQUID
`PREPARATIONS
`
`Group Art Unit 1614
`
`Examiner Charlesworth E. Rae
`
`Mail Stop: Amendment
`
`SUPPLEMENTAL AMENDMENT
`
`Commissioner for Patents
`
`P.O. Box 1450
`
`Alexandria, VA 22313-1450
`
`Sir:
`
`Further to Applicants’ Response dated October 9, 2007, please amend the above-
`
`identified application as follows:
`
`MYLAN EX. 1020, Page 1
`
`MYLAN Ex. 1020, Page 1
`
`

`
`Amendments to the Specification
`
`Page 10, lines 5-17, please rewrite as follows:
`
`The appearance after light irradiation did not change from that immediately after
`
`preparation and was pale yellow and clear for Formulation 10 (pH 4) and Formulation 11 (pH
`
`8.5) comprising sodium chloride. In addition, the appearance did not change from gag
`
`immediately after preparation and was colorless and clear for Formulation 12 having a
`
`bepotastine besilate concentration of 0.1 w/v%. These results and the results of Formulation 7
`
`(pH 6.8) in Experimental Example 2 indicate that addition of sodium chloride, which is a water-
`
`soluble metal chloride, improves light stability of bepotastine besilate at pH 4-8.5. In addition,
`
`they indicate that the light-stability of bepotastine besilate is improved in the concentration range
`
`of 0.1 w/v% - 1.5 w/v%.
`
`MYLAN EX. 1020, Page 2
`
`MYLAN Ex. 1020, Page 2
`
`

`
`Amendments to the Claims
`
`1. (Currently amended)
`
`An aqueous liquid preparation comprising (+)—(S)—4—[4-[(4-
`
`chlorophenyl)(2-pyridyl)methoxy]piperidino]butyric acid or a pharmacologically acceptable acid
`
`addition salt thereof, and a water-soluble metal chloride in an agueous solution.
`
`2. (Original)
`
`The aqueous liquid preparation of claim 1, wherein the metal chloride has
`
`a concentration selected from the range of a lower limit concentration of 0.15 w/v% and an upper
`
`limit concentration of 1.5 w/v%.
`
`3. (Previously presented)
`
`The aqueous liquid preparation of claim 1, wherein the metal
`
`chloride is at least one kind selected from sodium chloride, potassium chloride and calcium
`
`chloride.
`
`4. (Previously presented)
`
`The aqueous liquid preparation of claim 1, wherein the (+)-(S)-4-
`
`[4-[(4—chlorophenyl)(2-pyridyl)methoxy]piperidino]butyric acid or the pharmacologically
`
`acceptable acid addition salt thereof has a concentration selected from the range of a lower limit
`
`concentration of 0.1 w/v% and an upper limit concentration of 2.0 w/v%.
`
`5. (Previously presented)
`
`The aqueous liquid preparation of claim 1, which is an acid
`
`addition salt of (+)-(S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butyric acid.
`
`6. (Original)
`
`The aqueous liquid preparation of claim 5, wherein the acid addition salt is
`
`monobenzenesulfonate.
`
`7. (Previously presented)
`
`The aqueous liquid preparation of claim 1, wherein the aqueous
`
`liquid preparation has a pH in the range of 4-8.5.
`
`8. (Previously presented)
`
`The aqueous liquid preparation of claim 1, which is an eye drop.
`
`9. (Previously presented)
`
`The aqueous liquid preparation of claim 1, which is a nasal drop.
`
`MYLAN EX. 1020, Page 3
`
`MYLAN Ex. 1020, Page 3
`
`

`
`10. (Currently amended)
`
`An aqueous eye drop comprising (+)-(S)-4-[4-[(4-
`
`chloropheny1)(2-pyridyl)methoxy]piperidino]butyric acid monobenzenesulfonate and sodium
`
`chloride at not less than 0.2 w/v% and not more than 0.8 w/v% in an agueous solution.
`
`11. (Original)
`
`A method of light-stabilizing (+)-(S)-4-[4-[(4-ch1orophenyl)(2-
`
`pyridyl)methoxy]piperidino]butyric acid in an aqueous solution, which comprises adding a
`
`water-soluble metal chloride to an aqueous solution comprising (+)-(S)-4-[4-[(4-
`
`chlorophenyl)(2-pyridyl)methoxy]piperidino]butyric acid or a pharmacologically acceptable acid
`
`addition salt thereof.
`
`MYLAN EX. 1020, Page 4
`
`MYLAN Ex. 1020, Page 4
`
`

`
`REMARKS
`
`A further editorial change has been effected to the paragraph appearing on page 10, line
`
`Claims 1 and 10 have been further amended to specify that the preparation is “in an
`
`aqueous solution”. This is responsive to the Examiner’s statement on page 4, lines 3-4 of the
`
`Action that no patentable weight is given to the preamble of the former claims.
`
`In addition, there is submitted herewith an executed Rule 132 Declaration of Dr.
`
`Higashiyama. The Declaration sets forth the experiments of Experimental Examples 1-4 of the
`
`specification. As discussed in Applicants’ response of October 9, 2007, these experiments show
`
`the unexpected effect of this invention.
`
`In view of the foregoing, favorable consideration and allowance is solicited.
`
`Respectfully submitted,
`
`Masayo HIGASHIYAMA
`
`Bygai
`Warren M. Cheek
`
`Registration No. 33,367
`Attorney for Applicant
`
`WMC/dlk
`
`Washington, D.C. 20006-1021
`Telephone (202) 721-8200
`Facsimile (202) 721-8250
`November 13, 2007
`
`MYLAN EX. 1020, Page 5
`
`MYLAN Ex. 1020, Page 5

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket